Edmond de Rothschild (ERES IV), Advised by Elyan Partners, Acquires Majority Stake in Oncodesign Services
July 1, 2022
Edmond de Rothschild Equity Strategies IV SLP (ERES IV), advised by Elyan Partners, acquired a majority stake in Oncodesign Services (ODS), taking control of a 61.58% block and announcing a planned simplified tender offer (OPAS) for the remaining shares. The transaction separates Oncodesign's Services and Biotech businesses and positions ODS for accelerated organic growth and potential bolt-on acquisitions under continued management involvement from founder Philippe Genne and CEO Fabrice Viviani.
- Buyers
- Edmond de Rothschild Equity Strategies IV SLP (ERES IV), Elyan Partners
- Targets
- Oncodesign Services (Oncodesign / ODS)
- Sellers
- Philippe Genne (via holding P.C.G.) and other principal shareholders, certain managers and minority shareholders
- Industry
- Healthcare Services
- Location
- Bourgogne-Franche-Comté, France
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
Oncodesign Services Acquires ZoBio; Eurazeo's Nov Santé Invests in Oncodesign
January 23, 2023
Biotechnology
Oncodesign Services, majority-held by ERES IV SLP (Edmond de Rothschild Private Equity), has acquired Dutch fragment-based drug discovery specialist ZoBio to strengthen its upstream Drug Discovery capabilities. Concurrently, Nov Santé Actions Non Cotées (managed by Eurazeo) has invested in Oncodesign Services to support external growth and the group's international expansion.
-
Eurazeo to Acquire Eres Group Stake from IK Partners
April 22, 2024
Financial Services
Eurazeo has signed an agreement to acquire the stake in French fintech Eres Group from IK Partners' IK VIII Fund; financial terms were not disclosed and the transaction is subject to regulatory approvals. Eres, headquartered in Paris, is a leading provider of employee profit-sharing, retirement schemes and asset management with approximately €6.7 billion in assets under management and a distribution network of over 6,600 distributors.
-
IK Investment Partners to Acquire Majority Stake in Eres
February 20, 2019
Wealth Management
IK Investment Partners' IK VIII Fund has entered exclusive negotiations to acquire a majority stake in French employee-savings and retirement specialist Eres alongside Eres' management team and employees. The deal will see current investor Parquest Capital exit (or reduce its stake) as IK and management look to accelerate Eres' development; financial terms were not disclosed.
-
Reichmann Segal Acquires OES Inc.
April 7, 2025
Manufacturing
Reichmann Segal Capital Partners has acquired OES Inc. from Ardenton Capital Corporation in a move to expand its sports infrastructure platform and invest in electronic manufacturing services (EMS) and custom technologies. The deal will integrate OES' LED video scoreboards, EMS capabilities and scoring/timing software with Reichmann Segal's existing portfolio company Athletica, with OES CEO Jeff Stewart remaining in place; terms were not disclosed.
-
Elyan Partners Acquires Majority Stake in Stordata
March 26, 2024
IT Services
Funds advised by Elyan Partners (Edmond de Rothschild Private Equity) have acquired a majority stake in Stordata, a Versailles-based IT services and data management specialist. The acquisition was financed via a bespoke debt package arranged by H.I.G. WhiteHorse Europe with participation from Caisse d'Epargne et de Prévoyance Hauts de France to support Stordata's expansion and a buy-and-build strategy focused on cloud and cybersecurity.
-
Arcline Investment Management Acquires Engineering by Design
December 16, 2020
Medical Devices
Arcline Investment Management, a growth-oriented private equity firm, has acquired a controlling stake in Engineering by Design (EBD) from founders Dale and Judy Henson. EBD will join Arcline's medical-oriented manufacturing equipment platform (including Glebar, Everite Machine Products, SYNEO and Cath-Tip), expanding Arcline's capabilities in precision equipment and consumables for interventional medical device manufacturing.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.